$PAYX

Argus Adjusts Price Target on Paychex to $115 From $110, Maintains Buy Rating

Argus raised its price target for Paychex to $115 from $110, maintaining a buy rating. The stock has a 5-day change of -2.04% and a year-to-date change of -13.66%. TD Cowen also recently adjusted its target to $105 from $117, keeping a hold rating.

Original reporting
Published Sep 29, 2026, 10:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 11:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PAYX
Bullish
medium confidence
Mentioned
$PAYX
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$PAYXBullishLow
01

Why it matters

Analyst target changes can influence short-term trading sentiment but lack of fresh operational data limits impact.

02

Market read

Modest relevance; primarily of interest to traders tracking analyst upgrades.

03

What to watch

No new earnings or guidance data; price target change alone may not drive significant price movement.

Relevance 5/10Novelty 5/10Timing: pre-market today

Background

The article reports an analyst's price target adjustment for Paychex without providing new company fundamentals.

Company-level read

Ticker impact

$PAYXBullishMedium confidence
Context

Argus raised its price target for Paychex to $115 from $110, indicating a more favorable outlook.

Expected impact

potential slight upside as investors adjust expectations

Evidence & confidence

Target raise reflects improved valuation expectations but no new company fundamentals disclosed.

Market effects

May marginally benefit the payroll services sector as analysts view Paychex more favorably.

Limited to U.S. equities, no broader regional effect.

Minimal global impact.

Counterpoint

Target raise could be premature if underlying earnings growth does not meet expectations.

Key entities

  • Paychex

    Payroll and HR services provider.

  • Argus Research

    Equity research firm issuing the target update.

Related articles

$PAYXHighAI 8/10

Paychex (PAYX): The Segment Mix Shift Caught the Street Off Guard, But Guidance Did Not Move

Paychex (PAYX) reported Q1 FY2027 revenue of $1.6B (+6%) and adjusted EPS of $1.34 (+10%), beating estimates. PEO and Insurance Solutions revenue surged 12%, leading to raised full-year PEO guidance. Despite this, the stock sold off, prompting JPMorgan to upgrade to Neutral and raise its price target to $115. Analysts remain divided on the company's segment mix shift and future growth prospects.

$PAYXHighAI 9/10

Paychex Reports $1.63 Billion In Q1 Revenue As Net Income Increases 12% To $429.7 Million

Paychex reported Q1 2027 revenue of $1.63B, up 6% YoY, with net income rising 12% to $429.7M. Growth was driven by payroll, human capital management, and PEO businesses. Operating income increased 14% to $619.2M, while operating margin improved to 38%. The company also reported higher interest income and reduced acquisition-related expenses. Paychex declared $423.6M in dividends and has a $1B share repurchase program.

$PAYXMedAI 8/10

Paychex (PAYX) Beats EPS Estimates, But Slow Growth Weighs on Shares

Paychex (PAYX) reported fiscal Q1 2027 revenue of $1.6B (+6% YoY) and adjusted EPS of $1.34 (+10% YoY), beating estimates. Operating income rose 14% to $619.2M. The company raised guidance for PEO and Insurance Solutions revenue growth to 7-8%. However, total revenue growth outlook remains at 5-6%, and Management Solutions revenue grew just 4%. Shares fell due to slower growth concerns.